CBIS News and Press, Cannabis Science Inc From 09/25/18

Cronos Group (NASDAQ: CRON ) and Canopy Growth (NYSE: CGC ) are up  5%  and  4% , respectively, premarket benefiting from buying in Tilray ( +20% ). More news on: Cronos Group, Inc., Canopy Growth Corporation, Medical Marijuana, Inc., Healthcare stocks news, Consumer stocks ...

The losing streak continues, at least for the moment. More news on: New Age Beverages Corporation, Tilray, Inc., Canopy Growth Corporation, Consumer stocks news, Healthcare stocks news, Stocks on the move, Top stock market news, , News on ETFs, Read more ...

Tilray (NASDAQ: TLRY ) is down  13%  premarket on robust volume, leading cannabis stocks in the red as the open approaches. More news on: Tilray, Inc., Canopy Growth Corporation, Cronos Group, Inc., Healthcare stocks news, Consumer stocks news, Stocks on the move, News on ETFs, ...

IRVINE, CA, Sept. 21, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce the Company has appointed Dr. Jermane Bond, a noted research scientist, to its Scienti...

The House Judiciary Committee is about to vote on the Medical Cannabis Research Act of 2018 which would significantly increased the number of licenses allowing the domestic production of marijuana for research purposes. More news on: Canopy Growth Corporation, Medical Marijuana, Inc., Au...

IRVINE, CA, Sept. 12, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Cannabis Science, Inc. (OTC:  CBIS ), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce the launch of the Company’s new corporate advisory structur...

A U.S. House panel that oversees federal drug enforcement will vote this week on a bill that would require the federal government to issue more licenses to grow marijuana used in scientific studies, significantly expanding research opportunities in the field. More news on: Canopy Growth ...

Beverly Hills, CA, Sept. 07, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Crown Baus Capital Corporation (OTC: CBCA), a global acquisition-based conglomerate with investments primarily in five industries – High-Tech Incubation, Drug Development, Entertainment & Media, Education, ...

Cannabis stocks are showing some life premarket. Cronos Group (NASDAQ: CRON ) is up  24%  on robust volume, Canopy Growth (NYSE: CGC ) is up  7%  on increased volume and Tilray (NASDAQ: TLRY ) is up  11%  on average volume. More news on: Cronos Group, Inc., Ca...

Citron Research, a buyer of pot stock Tilray ( TLRY +9.4% ) up to $45, is now bearish with a fair value target of $26, calling it "by far the most expensive in the space." The stock is currently exchanging hands at $72 up over four-fold from its IPO price of $17. More news on: Tilray, In...